RXRX insider plans sale of 50,000 Class A shares
Christopher C. Gibson filed a notice to sell up to 50,000 Class A shares of RXRX through Fidelity Brokerage Services LLC, with an estimated aggregate market value of $168,500.00 on NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Christopher C. Gibson filed a notice to sell up to 50,000 Class A shares of RXRX through Fidelity Brokerage Services LLC, with an estimated aggregate market value of $168,500.00 on NASDAQ. The shares are described as Founders Shares originally acquired from the issuer on 04/20/2021 as compensation.
The filing also lists extensive Class A share sales during the prior three months by Christopher C. Gibson and related entities, including Gibson Family Trust and Lahwran-3 LLC, covering multiple transactions between 05/22/2026 and 08/10/2026, with individual trades ranging from 40,000 to 340,440 shares and transaction values up to about $1.09 million.
Key Figures
Key Terms
Form 144 regulatory
aggregate market value financial
Compensation financial
Class A financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is included in the RXRX Form 144 filed by Christopher C. Gibson?
AI-generated analysis. How Rhea-AI works. Not financial advice.